|
1
|
World Health Organization (WHO): Leprosy.
WHO, Geneva. 2018.https://www.who.int/en/news-room/fact-sheets/detail/leprosy.
Accessed February 9, 2018.
|
|
2
|
Britton WJ and Lockwood DN: Leprosy.
Lancet. 363:1209–1219. 2004.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ridley DS and Jopling WH: Classification
of leprosy according to immunity. A five-group system. Int J Lepr
Other Mycobact Dis. 34:255–273. 1966.PubMed/NCBI
|
|
4
|
Mira MT: Genetic host resistance and
susceptibility to leprosy. Microbes Infect. 8:1124–1131.
2006.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Alter A, Grant A, Abel L, Alcais A and
Schurr E: Leprosy as a genetic disease. Mamm Genome. 22:19–31.
2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhang FR, Huang W, Chen SM, Sun LD, Liu H,
Li Y, Cui Y, Yan XX, Yang HT, Yang RD, et al: Genomewide
association study of leprosy. N Engl J Med. 361:2609–2618.
2009.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Alonso A, Sasin J, Bottini N, Friedberg I,
Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J and Mustelin
T: Protein tyrosine phosphatases in the human genome. Cell.
117:699–711. 2004.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Andersen JN, Jansen PG, Echwald SM,
Mortensen OH, Fukada T, Del Vecchio R, Tonks NK and Møller NP: A
genomic perspective on protein tyrosine phosphatases: Gene
structure, pseudogenes, and genetic disease linkage. FASEB J.
18:8–30. 2004.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Davidson D, Cloutier JF, Gregorieff A and
Veillette A: Inhibitory tyrosine protein kinase p50csk is
associated with protein-tyrosine phosphatase PTP-PEST in
hemopoietic and non-hemopoietic cells. J Biol Chem.
272:23455–23462. 1997.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Cloutier JF and Veillette A: Cooperative
inhibition of T-cell antigen receptor signaling by a complex
between a kinase and a phosphatase. J Exp Med. 189:111–121.
1999.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Davidson D and Veillette A: PTP-PEST, a
scaffold protein tyrosine phosphatase, negatively regulates
lymphocyte activation by targeting a unique set of substrates. EMBO
J. 20:3414–3426. 2001.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Bottini N, Musumeci L, Alonso A, Rahmouni
S, Nika K, Rostamkhani M, MacMurray J, Meloni GF, Lucarelli P,
Pellecchia M, et al: A functional variant of lymphoid tyrosine
phosphatase is associated with type I diabetes. Nat Genet.
36:337–338. 2004.PubMed/NCBI View
Article : Google Scholar
|
|
13
|
Vang T, Congia M, Macis MD, Musumeci L,
Orrú V, Zavattari P, Nika K, Tautz L, Taskén K, Cucca F, et al:
Autoimmune-associated lymphoid tyrosine phosphatase is a
gain-of-function variant. Nat Genet. 37:1317–1319. 2005.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Chapman SJ, Khor CC, Vannberg FO, Maskell
NA, Davies CW, Hedley EL, Segal S, Moore CE, Knox K, Day NP, et al:
PTPN22 and invasive bacterial disease. Nat Genet. 38:499–500.
2006.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lamsyah H, Rueda B, Baassi L, Elaouad R,
Bottini N, Sadki K and Martin J: Association of PTPN22 gene
functional variants with development of pulmonary tuberculosis in
Moroccan population. Tissue Antigens. 74:228–232. 2009.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Lopez-Escamez JA: A variant of PTPN22 gene
conferring risk to autoimmune diseases may protect against
tuberculosis. J Postgrad Med. 56:242–243. 2010.PubMed/NCBI
|
|
17
|
Aliparasti MR, Almasi S, Majidi J, Zamani
F, Khoramifar AR and Azari ARF: Protein tyrosine phosphatase
non-receptor type 22 gene polymorphism C1858T is not associated
with leprosy in Azerbaijan, Northwest Iran. Indian J Hum Genet.
19:403–407. 2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Rani R, Singh A, Israni N, Singh A, Sharma
P and Kar HK: The role of polymorphic protein tyrosine phosphatase
non-receptor type 22 in leprosy. J Invest Dermatol. 129:2726–2728.
2009.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Rangel-Villalobos H, Muñoz-Valle JF,
González-Martín A, Gorostiza A, Magaña MT and Páez-Riberos LA:
Genetic admixture, relatedness, and structure patterns among
Mexican populations revealed by the Y-chromosome. Am J Phys
Anthropol. 135:448–461. 2008.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Rubi-Castellanos R, Anaya-Palafox M,
Mena-Rojas E, Bautista-España D, Muñoz-Valle JF and
Rangel-Villalobos H: Genetic data of 15 autosomal STRs (Identifiler
kit) of three Mexican Mestizo population samples from the States of
Jalisco (West), Puebla (Center), and Yucatan (Southeast). Forensic
Sci Int Genet. 3:e71–e76. 2009.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Miller SA, Dykes DD and Polesky HF: A
simple salting out procedure for extracting DNA from human
nucleated cells. Nucleic Acids Res. 16(1215)1988.PubMed/NCBI
|
|
22
|
Larrea MR, Carreño MC and Fine PE:
Patterns and trends of leprosy in Mexico: 1989-2009. Lepr Rev.
83:184–194. 2012.PubMed/NCBI
|
|
23
|
Aguilar-Medina M, Escamilla-Tilch M,
Frías-Castro LO, Romero-Quintana G, Estrada-García I, Estrada-Parra
S, Granados J, Arambula Meraz E, Sánchez-Schmitz G, Khader SA, et
al: HLA Alleles are genetic markers for susceptibility and
resistance towards leprosy in a Mexican Mestizo population. Ann Hum
Genet. 81:35–40. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Escamilla-Tilch M, Torres-Carrillo NM,
Payan RR, Aguilar-Medina M, Salazar MI, Fafutis-Morris M,
Arenas-Guzman R, Estrada-Parra S, Estrada-Garcia I and Granados J:
Association of genetic polymorphism of HLA-DRB1 antigens with the
susceptibility to lepromatous leprosy. Biomed Rep. 1:945–949.
2013.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Abdelrahman HM, Sherief LM, Abd Elrahman
DM, Alghobashy A, Elsaadani HF and Mohamed RH: The association of
PTPN22 (rs2476601) and IL2RA (rs11594656) polymorphisms with T1D in
Egyptian children. Hum Immunol. 77:682–686. 2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Song GG, Bae SC, Kim JH and Lee YH: The
PTPN22 C1858T polymorphism and rheumatoid arthritis: A
meta-analysis. Rheumatol Int. 33:1991–1999. 2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zheng J, Ibrahim S, Petersen F and Yu X:
Meta-analysis reveals an association of PTPN22 C1858T with
autoimmune diseases, which depends on the localization of the
affected tissue. Genes Immun. 13:641–652. 2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Maine CJ, Hamilton-Williams EE, Cheung J,
Stanford SM, Bottini N, Wicker LS and Sherman LA: PTPN22 alters the
development of regulatory T cells in the thymus. J Immunol.
188:5267–5275. 2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Saini C, Ramesh V and Nath I: Increase in
TGF-β secreting CD4(+)CD25(+) FOXP3(+) T regulatory cells in
anergic lepromatous leprosy patients. PLoS Negl Trop Dis.
8(e2639)2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kumar S, Naqvi RA, Ali R, Rani R, Khanna N
and Rao DN: FoxP3 provides competitive fitness to CD4(+)CD25(+) T
cells in leprosy patients via transcriptional regulation. Eur J
Immunol. 44:431–439. 2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kawasaki E, Awata T, Ikegami H, Kobayashi
T, Maruyama T, Nakanishi K, Shimada A, Uga M, Kurihara S, Kawabata
Y, et al: Systematic search for single nucleotide polymorphisms in
a lymphoid tyrosine phosphatase gene (PTPN22): association between
a promoter polymorphism and type 1 diabetes in Asian populations.
Am J Med Genet A. 140:586–593. 2006.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Torres-Carrillo NM, Ruiz-Noa Y,
Martínez-Bonilla GE, Leyva-Torres SD, Torres-Carrillo N,
Palafox-Sánchez CA, Navarro-Hernández RE, Rangel-Villalobos H,
Oregón-Romero E and Muñoz-Valle JF: The +1858C/T PTPN22 gene
polymorphism confers genetic susceptibility to rheumatoid arthritis
in Mexican population from the Western Mexico. Immunol Lett.
147:41–46. 2012.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Sridevi K, Neena K, Chitralekha KT, Arif
AK, Tomar D and Rao DN: Expression of costimulatory molecules
(CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR
gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of
leprosy patients using Mycobacterium leprae antigen (MLCWA) with
murabutide and T cell peptide of Trat protein. Int Immunopharmacol.
4:1–14. 2004.PubMed/NCBI View Article : Google Scholar
|
